Latest glioblastoma multiforme Stories
Company Plans for Multi-Pronged, Long Term Expansion of Novel Treatment Platform NEW YORK, Feb.
The hospital is among the first to offer the new technology for use in neuro-oncological radiation therapy New York,NY (PRWEB) January 30, 2015 NewYork-Presbyterian/Weill
Doctors at Atlantic NeuroSurgical Specialists (ANS) have added a new and innovative form of therapy to their treatment arsenal in the battle against glioblastoma multiforme (GBM).
BETHESDA, Md., Jan. 23, 2015 /PRNewswire/ -- Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)("NW Bio"), a U.S.
-- Increases Total Number of DelMar Patents Covering VAL-083 to Three US Patents and One International Patent -- VANCOUVER, British Columbia and MENLO PARK, Calif., Jan.
-- First Observation of Dose Limiting Toxicity Signals VAL-083's Potential Advancement Toward Registration Directed Clinical Trials in Refractory Glioblastoma -- VANCOUVER, British Columbia
Aldoxorubicin Showed 66% Complete or Partial Responses and No Tumor Progression in KS Patients with Excellent Tolerability LOS ANGELES, Jan.
SAN ANTONIO, Jan.
Aldoxorubicin Shows a Complete Response, Tumor Shrinkage, Prolonged Stable Disease, and Favorable Tolerability in Patients LOS ANGELES, Jan.